Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$235.67 +2.66 (+1.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Jazz Pharmaceuticals (JAZZ) Return on Sales [ROS] (2010 - 2026)

Updated

Jazz Pharmaceuticals' Return on Sales [ROS] was 20.54% in Q2 2026, up 86.18 percentage points from -65.64% a year earlier but down 10.95 percentage points from the prior quarter.

Analysis

Jazz Pharmaceuticals (JAZZ) Return on Sales [ROS] (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Jazz Pharmaceuticals' Return on Sales [ROS] was 19.49% through Jun 30, 2026, up 26.62 percentage points year-over-year; for FY2025, it was -10.08%, down 27.69 percentage points from FY2024.

  • Return on Sales [ROS] shows a five-year change of -26.08 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was 17.61% in FY2024 (+2.52 pp), 15.09% in FY2023 (+16.88 pp), -1.79% in FY2022 (-7.29 pp) and 5.50% in FY2021 (-10.49 pp).
  • Quarterly Return on Sales [ROS] has moved between -65.64% (Q2 2025) and 31.49% (Q1 2026) over five years.
  • Compared with a year earlier, Return on Sales [ROS] has increased for three straight quarters, with an average year-over-year change of +2.72 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q2 2026 (a gain of 86.18 percentage points); the worst was Q2 2025 (a drop of 85.12 percentage points).
  • Per Business Quant data, JAZZ's Return on Sales [ROS] in the three quarters before Q2 2026 was 31.49% (Q1 2026), 21.25% (Q4 2025) and 5.11% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Jazz Pharmaceuticals 15.30 Bn 9.12 Bn 1.09 Bn 20.54%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.54%
Mar 31, 2026 31.49%
Dec 31, 2025 21.25%
Sep 30, 2025 5.11%
Jun 30, 2025 -65.64%
Mar 31, 2025 -6.23%
Dec 31, 2024 17.53%
Sep 30, 2024 24.67%
Jun 30, 2024 19.48%
Mar 31, 2024 7.34%
Dec 31, 2023 12.11%
Sep 30, 2023 17.73%
Jun 30, 2023 16.47%
Mar 31, 2023 14.12%
Dec 31, 2022 -27.09%
Sep 30, 2022 2.63%
Jun 30, 2022 9.17%
Mar 31, 2022 10.76%
Dec 31, 2021 5.51%
Sep 30, 2021 3.38%
API Access

Jazz Pharmaceuticals Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=JAZZ&period=max&api_key=YOUR_API_KEY